INMODE LTD. 5,000,000 Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus • New York
InMode Ltd., a company organized under the laws of the State of Israel (the “Company”), proposes to sell 5,000,000 shares (the “Firm Shares”) of the Company’s ordinary shares, par value NIS 0.01 per ordinary share (the “Ordinary Shares”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to 750,000 additional Ordinary Shares on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the “Shares.” This Agreement is to confirm the agreement concerning the purchase of the Shares from the Company by the Underwriters.
INMODE LTD. RESTRICTED SHARE UNIT AWARD GRANT NOTICE AND RESTRICTED SHARE UNIT AWARD AGREEMENT FOR ALL PARTICIPANTS (OTHER THAN PARTICIPANTS IN ISRAEL)Restricted Share Unit Award Agreement • February 10th, 2022 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
This Grant Notice may be executed in one or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.
TURN - KEY MANUFACTURING AGREEMENTTurn-Key Manufacturing Agreement • February 10th, 2022 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
INMODE LTD., with a principal place of business at Tavor Building, Shaar Yokneam, POB 330, Yokneam 2069206, Israel. Hereinafter referred to as “Customer”
CONSULTANCY AGREEMENTConsultancy Agreement • July 11th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Whereas The Parties agree to amend the terms of the Previous Agreement and replace it with this Agreement, effective as of the Effective Date, and to establish the terms and basis of continuous engagement of the Principal as the CEO of the Company and the Group (as defined below), and to provide his management services to the Company via the Consultant;
Investment by Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP)Equity Joint Venture Agreement • July 11th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Animated by the purpose of facilitating the cooperation in the investment in the Bio-industry by the parties to this contract, in accordance with the “Law of the People’s Republic of China on Chinese-Foreign Equity Joint Ventures”, its detailed rules and other relevant laws and regulations of China, based on the principle of equality and mutual benefits, through friendly and candid consultation, all parties agree to jointly form, effective as of Closing, a Chinese Equity Joint Venture company in the Guangzhou Development District (the “GDD”)/Bio-Island which will be engaged in the territory of the mainland of People’s Republic of China, Hong Kong, Taiwan and Macau, in the (i) importation, distribution, marketing and sale of devices and certain products manufactured by Party B, and (ii) development, performance of clinical trials, design and manufacturing of devices and products, distribution, marketing and sale, support and provision of warranty based on Party B’s technology. In this r
TUNRKEY MANUFACTURING AGREEMENTTurnkey Manufacturing Agreement • July 29th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
INVASIX Ltd., with a principal place of business at Tavor building, POB 533, Yokneam, Israel, Hereinafter referred to as “Customer”
INMODE LTD. Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • July 11th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus • New York
InMode Ltd., a company organized under the laws of the State of Israel (the “Company”), proposes to sell [●] shares (the “Firm Shares”) of the Company’s ordinary shares, par value NIS 0.01 per ordinary share (the “Ordinary Shares”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to [●] additional Ordinary Shares on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the “Shares.” This Agreement is to confirm the agreement concerning the purchase of the Shares from the Company by the Underwriters.
OFFICES LEASE AGREEMENTOffices Lease Agreement • July 11th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Whereas The Landlord is the owner of the rights in the complex as defined in Appendix A to this contract and which includes, inter alia, the premises as defined below;
Addendum No. 3 to an Unprotected Lease Dated February 2018Unprotected Lease Addendum • February 10th, 2022 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Whereas in February 2018, the Landlord and the Tenant entered into a lease agreement, including the appendices and attachments thereto (hereinafter: the "Original Lease Agreement") for renting space as well as parking spaces, in a complex known as “Yokneam Gate" (hereinafter: the "Existing Premises" and the "Complex", respectively); and in January 2019 and in January 2020 the Landlord and the Tenant entered into addenda to the lease agreement to increase the area of the premises and to lease additional parking spaces, so that the Tenant leases from the Landlord a total of 1,672 sq.m. in the “Tavor Building” of the Complex, as well as 37 parking spaces (hereinafter, as applicable: "Addenda to the Lease Agreement", "Existing Premises", "Area of the Existing Premises” and "Parking Spaces");
INMODE LTD. INDEMNIFICATION AND EXCULPATION AGREEMENTIndemnification Agreement • July 11th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
This Indemnification and Exculpation Agreement (“Indemnification Agreement”) is being entered into effective as of ___________ __, 2019, pursuant to the resolutions of the Board of Directors of InMode Ltd., (Israeli Company No. 514073618) a company organized under the laws of the State of Israel (the “Company” and the “Board” respectively) dated _____________, 2019 as approved by the Company’s shareholders on _____________, 2019.
Wigmore Medical Limited (“Wigmore”) - Invasix Ltd (“Invasix”) Founders Memorandum of UnderstandingMemorandum of Understanding • July 11th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Employment AgreementEmployment Agreement • July 11th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus • Ontario
Invasix Corp., a company incorporated under the laws of Canada, whose head office address is: 30 East Beaver Creek Road, Unit 115, Richmond Hill Ontario, Toronto Canada (the “Company”);
FIRST ADDENDUM TO EMPLOYMENT AGREEMENTEmployment Agreement • February 13th, 2024 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
This First Addendum (the "Addendum") is made and entered effective as of the 1st day of January 2023 (the "Effective Date"), by and between:
InMode letterhead]Consent to Waive Equity Swap Provision of Mou • October 11th, 2018 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Reference is made to the Founders Memorandum of Understanding, dated as of March 4, 2014 (the “MOU”), by and between InMode Ltd. (formerly Invasix Ltd.) (“Inmode”) and Wigmore Medical Limited (“Wigmore”). As of the date of this letter, Wigmore holds 49% of the outstanding share capital of Invasix UK Ltd., a subsidiary of InMode (“Invasix UK”). Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the MOU.
AWARD AGREEMENTAward Agreement • July 11th, 2019 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
This Award Agreement (this “Award Agreement”) is entered into as of the date hereof, by between InMode Ltd., a private company No. 514073618 of Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 20692, Israel (the “Company”) and [____________________], [______] Passport / Israeli ID Number [___________], of [_________________________________________________] (the “Participant”) (the Company and the Participant, shall be referred collectively, as “Parties”, or individually, a “Party”).
AGREEMENTInvestment Agreement • November 12th, 2020 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Party A: Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP), acting by its general partner Guangzhou Elim Biotech Industrial Venture Capital Management Company (“GIBF”),
ADDENDUM NUMBER 2 TO UNPROTECTED TENANCY AGREEMENT EXECUTED IN FEBRUARY 2018 Made and executed in Yokneam on January __, 2020Unprotected Tenancy Agreement • February 10th, 2021 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
of which address for the purpose of this Addendum is: Shaar Yokneam Complex 28 HaKidma Street, Yokneam Ilit Hereinafter referred to as: the “Lessor”
Wigmore Medical Limited (“Wigmore”) - Invasix Ltd (“Invasix”) Founders Memorandum of UnderstandingMemorandum of Understanding • November 8th, 2018 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
InMode letterhead]Consent to Waive Equity Swap Provision • October 11th, 2018 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Reference is made to the agreement dated as of September 9th, 2016 (the “Agreement), by and between InMode Ltd. (formerly Invasix Ltd.) (“Inmode”) and Guangzhou Sino-Israel Bio-Industry Investment Fund (“GIBF”). As of the date of this letter, GIBF holds 49% of the outstanding share capital of Guangzhou InMode Medical Technology Ltd., a subsidiary of InMode Ltd.
Fourth Addendum to Unprotected Lease Agreement dated February 28, 2018 Held and signed in ________ on _9_ of month___3____ 2023Unprotected Lease Agreement • February 13th, 2024 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Between: Shaar Yokneam - Limited Partnership Partnership No.: 550014666 "Ofer Shear Yokneam", 28 Hakidama St., Yokneam (hereinafter: "Lessor")
FIRST ADDENDUM TO CONSULTANCY AGREEMENTConsultancy Agreement • February 13th, 2024 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
This First Addendum (the "Addendum") is made and entered effective as of the 1st day of January 2023 (the "Effective Date"), by and between:
AGREEMENTAgreement • April 26th, 2021 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Party A: Dilazar Limited, a company incorporated under the laws of Jersey, registered nu# 66820, of 1st Floor 2 Mulcaster Street St Helier Jersey JE2 3NJ, Channel Islands (“Dilazar”);
